Axcelis Technologies sells interest in joint venture SEN Corporation to Sumitomo Heavy Industries
Clients Axcelis Technologies, Inc.
Jones Day advised Axcelis Technologies, Inc. in the $133 million sale of its 50% interest in SEN Corporation to joint venture partner Sumitomo Heavy Industries, Ltd.
As part of the transaction, Axcelis and SEN entered cross licenses that will allow the two companies to continue to use certain patents and technical information owned by the other to make and sell ion implant systems on a worldwide, royalty-free, perpetual basis. Axcelis' license to SEN does not include patents, licenses, or technical information developed by Axcelis for the Optima HD, Optima XE, or any non-implant products. The transaction terminated all existing agreements among Axcelis, SHI and SEN relating to the SEN joint venture.